C3 and metabolic dysfunction-associated steatotic liver disease: Many studies have shown that complement C3 levels were higher in multiple metabolic diseases, including obesity, diabetes, and NAFLD, and an energy-restricted diet decreased plasma C3 levels in men with obesity [39–42].